Babylon Announces Update on Take Private Proposal
AUSTIN, Texas & LONDON & LAUSANNE, Switzerland--(BUSINESS WIRE)--Jun 23, 2023--
Stay updated with breaking news from Maze Labs. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
AUSTIN, Texas & LONDON & LAUSANNE, Switzerland--(BUSINESS WIRE)--Jun 23, 2023--
MindMaze, a global pioneer in neurotechnology and digital therapeutics (DTx) for neurological recovery and care, has been recognized as one of Switzerland's Best Managed Companies in 2022. This programme
MindMaze, a global leader in digital therapeutics (DTx) for neurological recovery and care, today announced the appointments of: Patricia Bradley as Chief Commercial Officer; Sue Olsen, MS, CCC-SLP as
MindMaze Expands Global Reach of Digital Neurotherapeutics Portfolio with Four New Partnerships LAUSANNE, Switzerland, May 3, 2021 /PRNewswire/ -- MindMaze Healthcare, a global pioneer in the multibillion-dollar digital neurotherapeutics market, today announced four new partnership agreements that bring MindMaze's digital neurotherapeutics to patients in Latin America, Middle East, Spain and Switzerland through agreements with Surgicorp, Alkholi, Guttmann Barcelona and Swiss Rehabilitation. With these agreements, MindMaze further expands its novel, protocolized, evidence-based interventions ...
MindMaze Defines the Future of Brain Health with Digital Neurotherapeutics Portfolio Provides an Update on the Product Portfolio and Clinical Pipeline News provided by Share this article LAUSANNE, Switzerland, April 15, 2021 /PRNewswire/ -- MindMaze Healthcare (MMHC), a global pioneer in the multibillion-dollar digital neurotherapeutics market, today shared its roadmap for its commercial product portfolio and clinical pipeline. MindMaze Healthcare is at the forefront of advancing innovative digital neurotherapeutics (DTx) solutions through a platform approach that combines highly engagi...